New Diagnostic Test Could Help Stem Cryptococcal Meningitis Deaths In Africa
Newsweek: How to Stop Crypto, A Deadly Disease So Neglected It’s Missed on the ‘Neglected’ List
“…[U.S.-based] Immuno Mycologics, aka Immy, started out in the late ’70s with a modest goal: make simpler tools to diagnose fungal infections. It’s now one of the fastest-growing private companies in the nation, built entirely on unique diagnostics. One of its most important developments in recent years is a rapid test, the Cryptococcal Antigen Lateral Flow Assay, or CrAg LFA, which global health experts believe could be key to stopping one of the planet’s biggest killers: cryptococcal meningitis…” (Adams, 1/4).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.